Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2026-03-20 00:00:00 ET · period of report 2026-03-19 · accession 0001193125-26-117675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2026-03-19 | ALDX | DOUGLAS RICHARD | Dir | P - Purchase | $1.40 | +70.0K | 195.0K | +56% | +$98.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-19 | P | A | 70,000 | $1.40 | 195,000 | D | — | — |